Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre

Mutation Research - Reviews in Mutation Research

Volumn 682, Issue 1, 2009, Pages 39-53

  Scharlau, Daniel ^a   Borowicki, Anke ^a   Habermann, Nina ^a   Hofmann, Thomas ^a   Klenow, Stefanie ^a   Miene, Claudia ^a   Munjal, Umang ^a   Stein, Katrin ^a   Glei, Michael ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Butyrate; Chemoprevention; Colorectal cancer; Dietary fibre; Drug metabolising enzymes; Gut fermentation

Indexed keywords

4 HYDROXYNONENAL; APIGENIN; BUTYRIC ACID; CARCINOGEN; CATALASE; COMPLEMENTARY DNA; COUMARIC ACID; DRUG METABOLIZING ENZYME; FERULIC ACID; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE A2; GLUTATHIONE TRANSFERASE A4; GLUTATHIONE TRANSFERASE M2; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; HISTONE DEACETYLASE; HYDROGEN PEROXIDE; INULIN; LIGNAN DERIVATIVE; LIPID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHYTIC ACID; RESORCINOL DERIVATIVE; SHORT CHAIN FATTY ACID;

ACETYLATION; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL TYPE; CHEMOPROPHYLAXIS; COLON CANCER; COLON FLORA; COLORECTAL CANCER; DETOXIFICATION; DIET; DIETARY FIBER; DNA DAMAGE; DNA MICROARRAY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FERMENTATION; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; HUMAN; NONHUMAN; PRIMARY PREVENTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

BUTYRATES; COLONIC NEOPLASMS; DIETARY FIBER; DNA DAMAGE; ENZYME ACTIVATION; FERMENTATION; GLUTATHIONE TRANSFERASE; HUMANS; HYDROGEN PEROXIDE; INTESTINES;

ANIMALIA;

EID: 68749119436     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2009.04.001     Document Type: Review

References (157)

1. World Cancer Research Fund/American Institute for Cancer Research, Food, Nutrition and the Prevention of Cancer: A Global Perspective, 1997.
2. WCRF/AICR, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective, Ref. Type: Report, 2007.
3. Chiu B.C., Ji B.T., Dai Q., Gridley G., McLaughlin J.K., Gao Y.T., Fraumeni Jr. J.F., and Chow W.H. Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 201-208
4. Le M.L., Hankin J.H., Wilkens L.R., Pierce L.M., Franke A., Kolonel L.N., Seifried A., Custer L.J., Chang W., Lum-Jones A., and Donlon T. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1259-1266
5. Shaheen N.J., Silverman L.M., Keku T., Lawrence L.B., Rohlfs E.M., Martin C.F., Galanko J., and Sandler R.S. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. JNCI Cancer Spectrum. 95 (2003) 154-159
6. Norat T., Bingham S., Ferrari P., Slimani N., Jenab M., Mazuir M., Overvad K., Olsen A., Tjonneland A., Clavel F., Boutron-Ruault M.C., Kesse E., Boeing H., Bergmann M.M., Nieters A., Linseisen J., Trichopoulou A., Trichopoulos D., Tountas Y., Berrino F., Palli D., Panico S., Tumino R., Vineis P., Bueno-de-Mesquita H.B., Peeters P.H., Engeset D., Lund E., Skeie G., Ardanaz E., Gonzalez C., Navarro C., Quiros J.R., Sanchez M.J., Berglund G., Mattisson I., Hallmans G., Palmqvist R., Day N.E., Khaw K.T., Key T.J., San J.M., Hemon B., Saracci R., Kaaks R., and Riboli E. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J. Natl. Cancer Inst. 97 (2005) 906-916
7. Bingham S.A., Day N.E., Luben R., Ferrari P., Slimani N., Norat T., Clavel-Chapelon F., Kesse E., Nieters A., Boeing H., Tjonneland A., Overvad K., Martinez c., Dorronsoro M., Gonzalez C.A., Key T.J., Trichopoulou A., Naska A., Vineis P., Tumino R., Krogh V., Bueno-de-Mesquita H.B., Peeters P.H., Berglund G., Hallmans G., Lund E., Skeie G., Kaaks R., and Riboli E. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361 (2003) 1496-1501
8. Peters U., Sinha R., Chatterjee N., Subar A.F., Ziegler R.G., Kulldorff M., Bresalier R., Weissfeld J.L., Flood A., Schatzkin A., and Hayes R.B. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361 (2003) 1491-1495
9. Sesink A.L., Termont D.S., Kleibeuker J.H., and van der Meer R. Red meat and colon cancer: dietary haem, but not fat, has cytotoxic and hyperproliferative effects on rat colonic epithelium. Carcinogenesis 21 (2000) 1909-1915
10. Sesink A.L., Termont D.S., Kleibeuker J.H., and van der Meer R. Red meat and colon cancer: dietary haem-induced colonic cytotoxicity and epithelial hyperproliferation are inhibited by calcium. Carcinogenesis 22 (2001) 1653-1659
11. Pierre F., Freeman A., Tache S., van der Meer R., and Corpet D.E. Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J. Nutr. 134 (2004) 2711-2716
12. Sawa T., Akaike T., Kida K., Fukushima Y., Takagi K., and Maeda H. Lipid peroxyl radicals from oxidized oils and heme-iron: implication of a high-fat diet in colon carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 1007-1012
13. Xu M., Bailey A.C., Hernaez J.F., Taoka C.R., Schut H.A., and Dashwood R.H. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 17 (1996) 1429-1434
14. Dashwood R.H., Xu M., Hernaez J.F., Hasaniya N., Youn K., and Razzuk A. Cancer chemopreventive mechanisms of tea against heterocyclic amine mutagens from cooked meat. Proc. Soc. Exp. Biol. Med. 220 (1999) 239-243
15. de V.J., Jonker-Termont D.S., van Lieshout E.M., Katan M.B., and van der M.R. Green vegetables, red meat and colon cancer: chlorophyll prevents the cytotoxic and hyperproliferative effects of haem in rat colon. Carcinogenesis 26 (2005) 387-393
16. Bruce W.R., Archer M.C., Corpet D.E., Medline A., Minkin S., Stamp D., Yin Y., and Zhang X.M. Diet, aberrant crypt foci and colorectal cancer. Mutat. Res. 290 (1993) 111-118
17. Corpet D.E., and Pierre F. Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 391-400
18. Hung H.C., Joshipura K.J., Jiang R., Hu F.B., Hunter D., Smith-Warner S.A., Colditz G.A., Rosner B., Spiegelman D., and Willett W.C. Fruit and vegetable intake and risk of major chronic disease. J. Natl. Cancer Inst. 96 (2004) 1577-1584
19. Michels K.B., Fuchs C.S., Giovannucci E., Colditz G.A., Hunter D.J., Stampfer M.J., and Willett W.C. Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 842-849
20. Schatzkin A., Lanza E., Corle D., Lance P., Iber F., Caan B., Shike M., Weissfeld J., Burt R., Cooper M.R., Kikendall J.W., and Cahill J. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N. Engl. J Med. 342 (2000) 1149-1155
21. Cummings J.H. The effect of dietary fiber on fecal weight and composition. In: Spiller G.A. (Ed). CRC Handbook of Dietary Fiber in Human Nutrition (2001), CRC Press 183-252
22. Spiller G.A., and Spiller M. Correlations of transit time to a critical fecal weight (CFW) and to substances associated with dietary fiber. In: Spiller G.A. (Ed). CRC Handbook of Dietary Fiber in Human Nutrition (2001), CRC Press 253-256
23. Gibson G.R., and Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125 (1995) 1401-1412
24. Ferguson L.R., Zhu S.T., and Harris P.J. Antioxidant and antigenotoxic effects of plant cell wall hydroxycinnamic acids in cultured HT-29 cells. Mol. Nutr. Food Res. 49 (2005) 585-593
25. Ferguson L.R., Lim I.F., Pearson A.E., Ralph J., and Harris P.J. Bacterial antimutagenesis by hydroxycinnamic acids from plant cell walls. Mutat. Res. 542 (2003) 49-58
26. Gibson G.R., Probert H.M., Loo J.V., Rastall R.A., and Roberfroid M.B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17 (2004) 259-275
27. Fotiadis C.I., Stoidis C.N., Spyropoulos B.G., and Zografos E.D. Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World J. Gastroenterol. 14 (2008) 6453-6457
28. Schatzkin A., Mouw T., Park Y., Subar A.F., Kipnis V., Hollenbeck A., Leitzmann M.F., and Thompson F.E. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am. J. Clin. Nutr. 85 (2007) 1353-1360
29. Ferguson L.R., Chavan R.R., and Harris P.J. Changing concepts of dietary fiber: implications for carcinogenesis. Nutr. Cancer 39 (2001) 155-169
30. van Loo J., Coussement P., de L.L., Hoebregs H., and Smits G. On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit. Rev. Food Sci. Nutr. 35 (1995) 525-552
31. Singh J., Rivenson A., Tomita M., Shimamura S., Ishibashi N., and Reddy B.S. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18 (1997) 833-841
32. Cummings J.H. Short chain fatty acids in the human colon. Gut 22 (1981) 763-779
33. Kobayashi H., and Fleming S.E. The source of dietary fiber influences-short chain fatty acid production and concentrations in the large bowel. In: Spiller G.A. (Ed). CRC Handbook of Dietary Fiber in Human Nutrition (2001), CRC Press 287-315
34. Roediger W.E. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83 (1982) 424-429
35. Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell Biochem. 42 (1982) 65-82
36. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45 (1985) 1-8
37. Scheppach W., and Weiler F. The butyrate story: old wine in new bottles?. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 563-567
38. Sengupta S., Muir J.G., and Gibson P.R. Does butyrate protect from colorectal cancer?. J. Gastroenterol. Hepatol. 21 (2006) 209-218
39. Pool-Zobel B., Veeriah S., and Bohmer F.D. Modulation of xenobiotic metabolising enzymes by anticarcinogens-focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat. Res. 591 (2005) 74-92
40. Hayes J.D., and Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30 (1995) 445-600
41. Ebert M.N., Beyer-Sehlmeyer G., Liegibel U.M., Kautenburger T., Becker T.W., and Pool-Zobel B.L. Butyrate induces glutathione S-transferase in human colon cells and protects from genetic damage by 4-hydroxy-2-nonenal. Nutr. Cancer 41 (2001) 156-164
42. Johnson I.T., Williamson G., and Musk S.R.R. Anticarcinogenic factors in plant foods: a new class of nutrients?. Nutr. Res. Rev. 7 (1994) 175-204
43. Hayes J.D., Flanagan J.U., and Jowsey I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 51-88
44. Cummings J.H., Pomare E.W., Branch W.J., Naylor C.P., and Macfarlane G.T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28 (1987) 1221-1227
45. Csordas A. Toxicology of butyrate and short-chain fatty acids. In: Hill M.J. (Ed). Role of Gut Bacteria in Human Toxicology and Pharmacology (1995), Taylor and Francis, London 105-127
46. Mortensen P.B., and Clausen M.R. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand. J. Gastroenterol. Suppl. 216 (1996) 132-148
47. Topping D.L., and Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81 (2001) 1031-1064
48. Augenlicht L.H., Mariadason J.M., Wilson A., Arango D., Yang W., Heerdt B.G., and Velcich A. Short chain fatty acids and colon cancer. J. Nutr. 132 (2002) 3804S-3808S
49. Lupton J.R. Butyrate and colonic cytokinetics: differences between in vitro and in vivo studies. Eur. J. Cancer Prev. 4 (1995) 373-378
50. Hague A., Singh B., and Paraskeva C. Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology 112 (1997) 1036-1040
51. Lupton J.R. Microbial degradation products influence colon cancer risk: the butyrate controversy. J. Nutr. 134 (2004) 479-482
52. Hayes J.D., and Strange R.C. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic. Res. 22 (1995) 193-207
53. Eaton D.L., and Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol. Sci. 49 (1999) 156-164
54. Awasthi Y.C., Sharma R., and Singhal S.S. Human glutathione S-transferases. Int. J. Biochem. 26 (1994) 295-308
55. Peters W.H., Roelofs H.M., Nagengast F.M., van J.H., and Tongeren. Human intestinal glutathione S-transferases. Biochem. J. 257 (1989) 471-476
56. Armstrong R.N. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem. Res. Toxicol. 10 (1997) 2-18
57. Townsend A.J., Fields W.R., Haynes R.L., Doss A.J., Li Y., Doehmer J., and Morrow C.S. Chemoprotective functions of glutathione S-transferases in cell lines induced to express specific isozymes by stable transfection. Chem. Biol. Interact. 111-112 (1998) 389-407
58. Berhane K., Widersten M., Engstrom A., Kozarich J.W., and Mannervik B. Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1480-1484
59. Hinson J.A., and Kadlubar F.F. Glutathione and glutathione transferases in the detoxification of drug and carcinogen metabolites. In: Sies H., and Ketterer B. (Eds). Glutathione Conjugation: Mechanisms and Biological Significance (1988), Academic Press, London 235-280
60. Baez S., Segura-Aguilar J., Widersten M., Johansson A.S., and Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 324 Pt 1 (1997) 25-28
61. Lampe J.W., Chen C., Li S., Prunty J., Grate M.T., Meehan D.E., Barale K.V., Dightman D.A., Feng Z., and Potter J.D. Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 787-793
62. Nijhoff W.A., and Peters W.H. Quantification of induction of rat oesophageal, gastric and pancreatic glutathione and glutathione S-transferases by dietary anticarcinogens. Carcinogenesis 15 (1994) 1769-1772
63. Hayes J.D., McLeod R., Ellis E.M., Pulford D.J., Ireland L.S., McLellan L.I., Judah D.J., Manson M.M., and Neal G.E. Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1. IARC Sci. Publ. (1996) 175-187
64. Coles B., Nowell S.A., MacLeod S.L., Sweeney C., Lang N.P., and Kadlubar F.F. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. Mutat. Res. 482 (2001) 3-10
65. Peters W.H., and Roelofs H.M. Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2. Biochem. J. 264 (1989) 613-616
66. Roberfroid M.B. Introducing inulin-type fructans. Br. J. Nutr. 93 Suppl. 1 (2005) S13-S25
67. Pool-Zobel B.L. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br. J. Nutr. 93 Suppl 1 (2005) S73-S90
68. Hague A., and Paraskeva C. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. Eur. J Cancer Prev. 4 (1995) 359-364
69. Finnie I.A., Dwarakanath A.D., Taylor B.A., and Rhodes J.M. Colonic mucin synthesis is increased by sodium butyrate. Gut 36 (1995) 93-99
70. Pool-Zobel B.L., Selvaraju V., Sauer J., Kautenburger T., Kiefer J., Richter K.K., Soom M., and Wolfl S. Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis 26 (2005) 1064-1076
71. Beyer-Sehlmeyer G., Glei M., Hartmann E., Hughes R., Persin C., Bohm V., Rowland I., Schubert R., Jahreis G., and Pool-Zobel B.L. Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources. Br. J. Nutr. 90 (2003) 1057-1070
72. Kautenburger T., Beyer-Sehlmeyer G., Festag G., Haag N., Kuhler S., Kuchler A., Weise A., Marian B., Peters W.H., Liehr T., Claussen U., and Pool-Zobel B.L. The gut fermentation product butyrate, a chemopreventive agent, suppresses glutathione S-transferase theta (hGSTT1) and cell growth more in human colon adenoma (LT97) than tumor (HT29) cells. J. Cancer Res. Clin. Oncol. 131 (2005) 692-700
73. Sauer J., Richter K.K., and Pool-Zobel B.L. Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells. J. Nutr. Biochem. 18 (2007) 736-745
74. Schäferhenrich A., Sendt W., Scheele J., Kuechler A., Liehr T., Claussen U., Rapp A., Greulich K.O., and Pool-Zobel B.L. Endogenously formed cancer risk factors induce damage-of p53 in human colon cells obtained from surgical samples. Food Chem. Toxicol. 41 (2003) 655-664
75. Sauer J., Richter K.K., and Pool-Zobel B.L. Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells. Br. J. Nutr. 97 (2007) 928-937
76. Richter M., Jurek D., Wrba F., Kaserer K., Wurzer G., Karner-Hanusch J., and Marian B. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur. J. Cancer 38 (2002) 1937-1945
77. Schaeferhenrich A., Beyer-Sehlmeyer G., Festag G., Kuechler A., Haag N., Weise A., Liehr T., Claussen U., Marian B., Sendt W., Scheele J., and Pool-Zobel B.L. Human adenoma cells are highly susceptible to the genotoxic action of 4-hydroxy-2-nonenal. Mutat. Res. 526 (2003) 19-32
78. Ebert M.N., Klinder A., Peters W.H., Schaferhenrich A., Sendt W., Scheele J., and Pool-Zobel B.L. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24 (2003) 1637-1644
79. Cotton S.C., Sharp L., Little J., and Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol. 151 (2000) 7-32
80. Grubben M.J., Nagengast F.M., Katan M.B., and Peters W.H. The glutathione biotransformation system and colorectal cancer risk in humans. Scand. J. Gastroenterol. Suppl. (2001) 68-76
81. Forsberg L., Lyrenas L., de F.U., and Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic. Biol. Med. 30 (2001) 500-505
82. Kiefer J., Beyer-Sehlmeyer G., and Pool-Zobel B.L. Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells. Br. J. Nutr. 96 (2006) 803-810
83. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
84. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
85. Miyanishi K., Takayama T., Ohi M., Hayashi T., Nobuoka A., Nakajima T., Takimoto R., Kogawa K., Kato J., Sakamaki S., and Niitsu Y. Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology 121 (2001) 865-874
86. Barker H.J., Alpert L.C., Compton C.C., Maslen A., and Kirby G.M. Loss of glutathione S-transferase (GST) mu phenotype in colorectal adenocarcinomas from patients with a GSTM1 positive genotype. Cancer Lett. 177 (2002) 65-74
87. Nguyen T., Sherratt P.J., and Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 233-260
88. Jaiswal A.K. Antioxidant response element. Biochem. Pharmacol. 48 (1994) 439-444
89. Lee J.S., and Surh Y.J. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 224 (2005) 171-184
90. Kwon K.H., Barve A., Yu S., Huang M.T., and Kong A.N. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol. Sin. 28 (2007) 1409-1421
91. Chen C., Pung D., Leong V., Hebbar V., Shen G., Nair S., Li W., and Kong A.N. Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radic. Biol. Med. 37 (2004) 1578-1590
92. Zhang Y., Gonzalez V., and Xu M.J. Expression and regulation of glutathione S-transferase P1-1 in cultured human epidermal cells. J. Dermatol. Sci. 30 (2002) 205-214
93. Kweon M.H., In P.Y., Sung H.C., and Mukhtar H. The novel antioxidant 3-O-caffeoyl-1-methylquinic acid induces Nrf2-dependent phase II detoxifying genes and alters intracellular glutathione redox. Free Radic. Biol. Med. 40 (2006) 1349-1361
94. Minucci S., and Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6 (2006) 38-51
95. Burger-van Paassen N., Vincent A., Puiman P.J., van der Sluis M., Bouma J., Boehm G., van Goudoever J.B., Van Seuningen I I., and Renes I.B. The regulation of the intestinal mucin MUC2 expression by short chain fatty acids: implications for epithelial protection. Biochem. J. (2009)
96. Santini V., Gozzini A., and Ferrari G. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr. Drug Metab. 8 (2007) 383-393
97. Desmots F., Rauch C., Henry C., Guillouzo A., and Morel F. Genomic organization, 5′-flanking region and chromosomal localization of the human glutathione transferase A4 gene. Biochem. J. 336 Pt 2 (1998) 437-442
98. Turjanski A.G., Vaque J.P., and Gutkind J.S. MAP kinases and the control of nuclear events. Oncogene 26 (2007) 3240-3253
99. Tsai C.W., Chen H.W., Yang J.J., Sheen L.Y., and Lii C.K. Diallyl disulfide and diallyl trisulfide up-regulate the expression of the pi class of glutathione S-transferase via an AP-1-dependent pathway. J. Agric. Food Chem. 55 (2007) 1019-1026
100. Desmots F., Rissel M., Gilot D., Lagadic-Gossmann D., Morel F., Guguen-Guillouzo C., Guillouzo A., and Loyer P. Pro-inflammatory cytokines tumor necrosis factor alpha and interleukin-6 and survival factor epidermal growth factor positively regulate the murine GSTA4 enzyme in hepatocytes. J. Biol. Chem. 277 (2002) 17892-17900
101. Shah P., Nankova B.B., Parab S., La E.F., and Gamma. Short chain fatty acids induce TH gene expression via ERK-dependent phosphorylation of CREB protein. Brain Res. 1107 (2006) 13-23
102. Yang J., Kawai Y., Hanson R.W., and Arinze I.J. Sodium butyrate induces transcription from the G alpha(i2) gene promoter through multiple Sp1 sites in the promoter and by activating the MEK-ERK signal transduction pathway. J. Biol. Chem. 276 (2001) 25742-25752
103. Glei M., Hofmann T., Kuster K., Hollmann J., Lindhauer M.G., and Pool-Zobel B.L. Both wheat (Triticum aestivum) bran arabinoxylans and gut flora-mediated fermentation products protect human colon cells from genotoxic activities of 4-hydroxynonenal and hydrogen peroxide. J. Agric. Food Chem. 54 (2006) 2088-2095
104. Hansson L.O., Bolton-Grob R., Massoud T., and Mannervik B. Evolution of differential substrate specificities in Mu class glutathione transferases probed by DNA shuffling. J. Mol. Biol. 287 (1999) 265-276
105. Zimniak P., Singhal S.S., Srivastava S.K., Awasthi S., Sharma R., Hayden J.B., and Awasthi Y.C. Estimation of genomic complexity, heterologous expression, and enzymatic characterization of mouse glutathione S-transferase mGSTA4-4 (GST 5.7). J. Biol. Chem. 269 (1994) 992-1000
106. Ranganna K., Mathew O.P., Yatsu F.M., Yousefipour Z., Hayes B.E., and Milton S.G. Involvement of glutathione/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation. FEBS J. 274 (2007) 5962-5978
107. Helsby N.A., Zhu S., Pearson A.E., Tingle M.D., and Ferguson L.R. Antimutagenic effects of wheat bran diet through modification of xenobiotic metabolising enzymes. Mutat. Res. 454 (2000) 77-88
108. Challa A., Rao D.R., Chawan C.B., and Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18 (1997) 517-521
109. Abrahamse S.L., Pool-Zobel B.L., and Rechkemmer G. Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. Carcinogenesis 20 (1999) 629-634
110. Rosignoli P., Fabiani R., De B.A., Spinozzi F., Agea E., Pelli M.A., and Morozzi G. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 22 (2001) 1675-1680
111. Kuroda J., Urade M., Kishimoto H., Noguchi K., Hashitani S., Sakurai K., Nishimura N., and Hashimoto-Tamaoki T. Promotion of cell differentiation, and suppression of cell growth and cyclooxygenase-2 expression by differentiation-inducing agents in human oral squamous carcinoma SCC25 cells. Int. J. Oncol. 26 (2005) 361-367
112. Glei M., Liegibel U.M., Ebert M.N., Bohm V., and Pool-Zobel B.L. Beta-carotene reduces bleomycin-induced genetic damage in human lymphocytes. Toxicol. Appl. Pharmacol. 179 (2002) 65-73
113. Schmezer P., Rajaee-Behbahani N., Risch A., Thiel S., Rittgen W., Drings P., Dienemann H., Kayser K.W., Schulz V., and Bartsch H. Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes. Mutagenesis 16 (2001) 25-30
114. Knoll N., Ruhe C., Veeriah S., Sauer J., Glei M., Gallagher E.P., and Pool-Zobel B.L. Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate. Toxicol. Sci. 86 (2005) 27-35
115. Yadav U.C., Ramana K.V., Awasthi Y.C., and Srivastava S.K. Glutathione level regulates HNE-induced genotoxicity in human erythroleukemia cells. Toxicol. Appl. Pharmacol. 227 (2008) 257-264
116. Falletti O., and Douki T. Low glutathione level favors formation of DNA adducts to 4-hydroxy-2(E)-nonenal, a major lipid peroxidation product. Chem. Res. Toxicol. 21 (2008) 2097-2105
117. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat. Res. 463 (2000) 247-283
118. Diah S.K., Smitherman P.K., Townsend A.J., and Morrow C.S. Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1. Toxicol. Appl. Pharmacol. 157 (1999) 85-93
119. Ciaccio P.J., Shen H., Jaiswal A.K., Lyttle M.H., and Tew K.D. Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors. Mol. Pharmacol. 48 (1995) 639-647
120. Johansson A.S., Ridderstrom M., and Mannervik B. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I. Mol. Pharmacol. 57 (2000) 619-624
121. Humphries A., and Wright N.A. Colonic crypt organization and tumorigenesis. Nat. Rev. Cancer 8 (2008) 415-424
122. Thornalley P.J. Isothiocyanates: mechanism of cancer chemopreventive action. Anticancer Drugs 13 (2002) 331-338
123. Guengerich F.P., McCormick W.A., and Wheeler J.B. Analysis of the kinetic mechanism of haloalkane conjugation by mammalian theta-class glutathione transferases. Chem. Res. Toxicol. 16 (2003) 1493-1499
124. Ainbinder E., Bergelson S., Pinkus R., and Daniel V. Regulatory mechanisms involved in activator-protein-1 (AP-1)-mediated activation of glutathione-S-transferase gene expression by chemical agents. Eur. J. Biochem. 243 (1997) 49-57
125. Caderni G., Luceri C., De F.C., Salvadori M., Giannini A., Tessitore L., and Dolara P. Slow-release pellets of sodium butyrate do not modify azoxymethane (AOM)-induced intestinal carcinogenesis in F344 rats. Carcinogenesis 22 (2001) 525-527
126. Femia A.P., Luceri C., Dolara P., Giannini A., Biggeri A., Salvadori M., Clune Y., Collins K.J., Paglierani M., and Caderni G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23 (2002) 1953-1960
127. Pool-Zobel B.L., and Glei M. Experimental approaches to assess dietary fibre-mediated mechanisms of chemoprotection: in vitro studies with human colon cells in culture (Mini Review). Cancer Prev. Res. 11 (2006) 151-161
128. Pool-Zobel B.L., and Sauer J. Overview of experimental data on reduction of colorectal cancer risk by inulin-type fructans. J. Nutr. 137 (2007) 2580S-2584S
129. Rechkemmer G., Wahl M., Kuschinsky W., and Von E.W. pH-microclimate at the luminal surface of the intestinal mucosa of guinea pig and rat. Pflugers Arch. 407 (1986) 33-40
130. Perrin P., Pierre F., Patry Y., Champ M., Berreur M., Pradal G., Bornet F., Meflah K., and Menanteau J. Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut 48 (2001) 53-61
131. Silvester K.R., Bingham S.A., Pollock J.R., Cummings J.H., and O'Neill I.K. Effect of meat and resistant starch on fecal excretion of apparent N-nitroso compounds and ammonia from the human large bowel. Nutr. Cancer 29 (1997) 13-23
132. Gamet L., Daviaud D., is-Pouxviel C., Remesy C., and Murat J.C. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. Int. J. Cancer 52 (1992) 286-289
133. Ferguson L.R., and Harris P.J. Protection against cancer by wheat bran: role of dietary fibre and phytochemicals. Eur. J. Cancer Prev. 8 (1999) 17-25
134. Buri R.C., von Reding W., and Gavin M.H. Description and characterisation of wheat aleuron. Cereal Foods World 49 (2004) 275-281 Ref. Type: Generic
135. Shamsuddin A.M., and Ullah A. Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 10 (1989) 625-626
136. Shamsuddin A.M. Anti-cancer function of phytic acid. Int. J. Food Sci. Technol. 37 (2008) 769-782
137. Ross A.B., Kamal-Eldin A., and Aman P. Dietary alkylresorcinols: absorption, bioactivities, and possible use as biomarkers of whole-grain wheat- and rye-rich foods. Nutr. Rev. 62 (2004) 81-95
138. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 3 (2002) 364-373
139. Reddy B.S., Hirose Y., Cohen L.A., Simi B., Cooma I., and Rao C.V. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Cancer Res. 60 (2000) 4792-4797
140. Yang C.S., Landau J.M., Huang M.T., and Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21 (2001) 381-406
141. Ogiwara T., Satoh K., Kadoma Y., Murakami Y., Unten S., Atsumi T., Sakagami H., and Fujisawa S. Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res. 22 (2002) 2711-2717
142. Ozaki Y. Antiinflammatory effect of tetramethylpyrazine and ferulic acid. Chem. Pharmaceut. Bull. 40 (1992) 954-956
143. Hirose M., Takahashi S., Ogawa K., Futakuchi M., and Shirai T. Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis. Food Chem. Toxicol. 37 (1999) 985-992
144. Huang M.T., Smart R.C., Wong C.Q., and Conney A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48 (1988) 5941-5946
145. Aura A.M., Harkonen H., Fabritius M., and Poutanen K. Development of an in vitro enzymic digestion method for removal of starch and protein and assessment of its performance using rye and wheat breads. J. Cereal Sci. 29 (1999) 139-152
146. Wang X., and Gibson G.R. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J. Appl. Bacteriol. 75 (1993) 373-380
147. Barry J.L., Hoebler C., Macfarlane G.T., Macfarlane S., Mathers J.C., Reed K.A., Mortensen P.B., Nordgaard I., Rowland I.R., and Rumney C.J. Estimation of the fermentability of dietary fibre in vitro: a European interlaboratory study. Br. J. Nutr. 74 (1995) 303-322
148. Macfarlane G.T., Macfarlane S., and Gibson G.R. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb. Ecol. 35 (1998) 180-187
149. Venema K., Minekus M., and Havenaar R. Advanced in vitro models of gastrointestinal tract-novel tools to study functionality of dietary fibres. In: van der Kamp J.W., Asp N.G., Miller-Jones J., and Schaafsma G. (Eds). Dietary Fibre-bio-active Carbohydrates for Food and Feed (2004), Wageningen Academic Publishers 99-112
150. Klinder A., Gietl E., Hughes R., Jonkers N., Karlsson P., McGlyn H., Pistoli s., Tuohy K.M., Rafter J., Rowland I.R., Van Loo J., and Pool-Zobel B.L. Gut fermentation products of inulin-derived prebiotics inhibit markers of tumour progression in human colon tumour cells. Int. J. Cancer Prev. 1 (2004) 19-32
151. Chow H.H., Hakim I.A., Vining D.R., Crowell J.A., Tome M.E., Ranger-Moore J., Cordova C.A., Mikhael D.M., Briehl M.M., and Alberts D.S. Modulation of human glutathione s-transferases by polyphenon e intervention. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1662-1666
152. Fassler C., Gill C.I., Arrigoni E., Rowland I., and Amado R. Fermentation of resistant starches: influence of in vitro models on colon carcinogenesis. Nutr. Cancer 58 (2007) 85-92
153. Bajka B.H., Clarke J.M., Cobiac L., and Topping D.L. Butyrylated starch protects colonocyte DNA against dietary protein-induced damage in rats. Carcinogenesis 29 (2008) 2169-2174
154. Toden S., Bird A.R., Topping D.L., and Conlon M.A. Dose-dependent reduction of dietary protein-induced colonocyte DNA damage by resistant starch in rats correlates more highly with caecal butyrate than with other short chain fatty acids. Cancer Biol. Ther. 6 (2007) 253-258
155. Toden S., Bird A.R., Topping D.L., and Conlon M.A. High red meat diets induce greater numbers of colonic DNA double-strand breaks than white meat in rats: attenuation by high-amylose maize starch. Carcinogenesis 28 (2007) 2355-2362
156. de Bruin W.C., Wagenmans M.J., Board P.G., and Peters W.H. Expression of glutathione S-transferase theta class isoenzymes in human colorectal and gastric cancers. Carcinogenesis 20 (1999) 1453-1457
157. G. Festag. Charakterisierung der GST-Isoenzyme der humanen Kolonzelllinie LT97-eine neue Zelllinie aus einem früheren Adenomstadium. Friedrich Schiller University Jena. Ref. Type: Thesis/Dissertation, 2002.